{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:55:17Z","timestamp":1783608917862,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374102"],"award-info":[{"award-number":["82374102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025C02174"],"award-info":[{"award-number":["2025C02174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["MS25H270057"],"award-info":[{"award-number":["MS25H270057"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017940","name":"Zhejiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["ZJ2024067"],"award-info":[{"award-number":["ZJ2024067"]}],"id":[{"id":"10.13039\/100017940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114768","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:19:11Z","timestamp":1746422351000},"page":"114768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a"],"prefix":"10.1016","volume":"157","author":[{"given":"Congcong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglu","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.114768_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2025.114768_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114768_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med. (Lond.)"},{"issue":"Suppl","key":"10.1016\/j.intimp.2025.114768_bb0020","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.3350\/cmh.2022.0329","article-title":"Non-alcoholic fatty liver disease: the pathologist's perspective","volume":"29","author":"Leow","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"22","key":"10.1016\/j.intimp.2025.114768_bb0025","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.3748\/wjg.v30.i22.2829","article-title":"Management of non-alcoholic fatty liver disease: lifestyle changes","volume":"30","author":"Lv","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114768_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114768_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.intimp.2025.114768_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated MASLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.114768_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155313","article-title":"Alisol B regulates AMPK\/mTOR\/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia","volume":"128","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.intimp.2025.114768_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1142\/S0192415X23500301","article-title":"Therapeutic effects of Alisma orientale and its active constituents on cardiovascular disease and obesity","volume":"51","author":"Wu","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.intimp.2025.114768_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.911196","article-title":"Alisol B 23-acetate ameliorates lipopolysaccharide-induced intestinal barrier dysfunction by inhibiting TLR4-NOX1\/ROS signaling pathway in Caco-2 cells","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114768_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175942","article-title":"Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue","volume":"956","author":"Yang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114768_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/nu14122411","article-title":"Alisol B alleviates hepatocyte lipid accumulation and lipotoxicity via regulating RAR\u03b1-PPAR\u03b3-CD36 Cascade and attenuates non-alcoholic steatohepatitis in mice","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2025.114768_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108132","article-title":"Design, synthesis and biological evaluation of Alisol B derivatives for potential treatment of non-alcoholic steatohepatitis","volume":"155","author":"Yu","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.114768_bb0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7150\/ijbs.78097","article-title":"Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2025.114768_bb0080","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking MASLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.intimp.2025.114768_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101725","article-title":"Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism","volume":"72","author":"Chalhoub","year":"2023","journal-title":"Mol Metab"},{"issue":"8","key":"10.1016\/j.intimp.2025.114768_bb0090","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/dmd.111.039628","article-title":"Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2","volume":"39","author":"Wang","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2025.114768_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107852","article-title":"Discovery of the FXR\/CES2 dual modulator LE-77 for the treatment of irinotecan-induced delayed diarrhea","volume":"153","author":"Cao","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.114768_bb0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/mol.111.077099","article-title":"P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine","volume":"82","author":"Lagas","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114768_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101600","article-title":"Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma","volume":"65","author":"Chen","year":"2022","journal-title":"Mol Metab"},{"issue":"6","key":"10.1016\/j.intimp.2025.114768_bb0110","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.28472","article-title":"Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2025.114768_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2022.11.012","article-title":"Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-PKC\u03b5 signaling axis","volume":"35","author":"Zheng","year":"2023","journal-title":"Cell Metab."},{"issue":"17","key":"10.1016\/j.intimp.2025.114768_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140989","article-title":"Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice","volume":"131","author":"Singh","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2025.114768_bb0125","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1194\/jlr.M800614-JLR200","article-title":"Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity","volume":"50","author":"Sapiro","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2025.114768_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101977","article-title":"Liver matrin-3 protects mice against hepatic steatosis and stress response via constitutive androstane receptor","volume":"86","author":"Cheng","year":"2024","journal-title":"Mol. Metab."},{"issue":"41","key":"10.1016\/j.intimp.2025.114768_bb0135","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Spatial transcriptomic study reveals heterogeneous metabolic adaptation and a role of Pericentral PPAR\u03b1\/CAR\/Ces2a Axis during fasting in mouse liver","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"10.1016\/j.intimp.2025.114768_bb0140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/mol.107.041012","article-title":"Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression","volume":"73","author":"Roth","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"34","key":"10.1016\/j.intimp.2025.114768_bb0145","doi-asserted-by":"crossref","first-page":"12279","DOI":"10.1074\/jbc.REV120.011356","article-title":"From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases","volume":"295","author":"Zhao","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.114768_bb0150","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.intimp.2025.114768_bb0155","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.intimp.2025.114768_bb0160","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","article-title":"TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation","volume":"17","author":"Park","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2025.114768_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114768_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155200","article-title":"Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway","volume":"131","author":"Yan","year":"2022","journal-title":"Metabolism"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925007581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925007581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:39Z","timestamp":1778619519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925007581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S1567576925007581"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114768","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114768"}}